Ixazomib Citrate Market Analysis- Industry Size, Share, Research Report, Insights, Statistics, Trends, Growth and Forecast 2024-2034
Ixazomib Citrate is an oral proteasome inhibitor used in the treatment of multiple myeloma, a type of blood cancer. It works by inhibiting the activity of proteasomes, which are protein complexes that play a critical role in maintaining cell function by degrading damaged or unneeded proteins. By inhibiting proteasomes, Ixazomib Citrate causes an accumulation of proteins within cancer cells,...
0 Comments 0 Shares 149 Views 0 Reviews
Sponsored